BEC develops robotics for medical technology and is certified according to DIN EN ISO 13485. The product portfolio includes robotic applications for patient positioning, intervention and strength training.
"guidoo" is a robotic assistance system. Based on VT imaging data, guidoo supports the practitioner in safe navigation and positioning.
For example, its robotic arm guides a needle sleeve to the planned puncture site. The specialist inserts the biopsy needle through a guide sleeve, while guidoo supports positioning and angulation of the needle and specifies the insertion depth. This increases the hit rate, avoids control scans and protects the patient.
The patient positioning system exacure enables high-precision irradiation of tumors. It includes more than 15 years of experience in robotic patient positioning and is successfully used in proton, ion, and boron neutron capture therapy. In the field of BNCT, it is the first certified complete system on the market that guarantees the safe function of all components even under the influence of neutron radiation. By ceiling mounting with linear axis, exacure positions patients reliably and flexibly in front of the treatment beam with up to 7 degrees of freedom. The position of the patient couch is monitored in real time by the exatrack camera system. Thanks to its extensive modular design, the modular positioning system can be adapted to existing and new treatment rooms and expanded at any time. All modules communicate via the powerful exacontrol control system. Sophisticated technology and innovative neutron shielding ensure the system's long service life even under radiation exposure.
Strength training requires guided movements with varying forces. The "RoboGym" training robot revolutionizes this training: Its sensors and position data record the athlete's movements and forces in real time. It analyzes performance and provides direct bio-feedback for more efficient and injury-free training. A Digital Twin stores all training data, which is available in the cloud anytime and anywhere.